Cipla Limited
3 recalls on record · Latest: Dec 10, 2025
Subscribe to new Cipla Limited recalls (RSS)
Agency notice ledger
Federal filing book Cipla Limited LIGHT-BOOK · SINGLE-AGENCY
#3,477 of 14,151 · 3 notices · 0.003% archive
- BOOK 3 notices
- RANK #3,477 of 14,151
- SHARE 0.003% archive
- AGENCY FDA Drug (3)
- CAT drugs
- CATS 2 categories
- LATEST Dec 10, 2025
- PHOTO 3B Medical, Inc.
Nearest notice-volume peer: 3B Medical, Inc. (0 notice gap)
Cipla Limited accounts for about 0.003% of the 104,423-notice archive on 3 distinct filings — a light share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →
How Cipla Limited compares to 14,151 recalling firms
Cipla Limited ranks 3,477th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.
Cipla Limited vs all firms by recall-notice count
Where this firm's archive sits among every tracked recalling manufacturer
3 3477th of 14151 higher than 9,908 of 14,151 firms
Firms, banded by distinct federal recall-event inventory
Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13
Cipla Limited in the notice-volume neighbourhood
Distinct federal recall events among this firm and nearest nationwide peers
- Cipla Limited (this)
Cipla Limited
3 notices
- 3B Medical, I…
3B Medical, Inc.
3 notices
- 7-Eleven, Inc.
7-Eleven, Inc.
3 notices
- A & C Best Fo…
A & C Best Food Trading
3 notices
- A B Nutrition…
A B Nutrition, Inc.
3 notices
- A L I Technol…
A L I Technologies Ltd
3 notices
What this shows Cipla Limited holds about 0.003% of archive notices alongside 3 distinct filings.
Phytonadione Injectable Emulsion, USP 10mg/mL, 10x1 mL Single-Dose Vial/carton, Rx Only, Mfd. by: Cipla Ltd. India At M/s Immacule Lifesciences PVT. Ltd. India. Mfd. for: Cipla USA, Inc. Warren, NJ 07059. Vial NDC# 69097-708-31; Carton NDC 69097-708-96
Nevirapine Extended Release Tablets, 400 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd. Verna Goa, India, Manufactured for: Cipla USA Inc. 9100 S Dadeland Blvd., Suite 1500 Miami, FL 33156, NDC 69097-403-02
Levalbuterol Inhalation Solution, USP, 0.31 mg/ 3 mL, 3 mL Vials, Rx Only. Manufactured by: Cipla Ltd. Plot 9 & 10, Indure, SEZ, Pithampur, M.P.-454 775, INDIA, Manufactured for: Dr. Reddy's Laboratories, Inc., Princeton NJ 08640. NDC: 43598-412-25.
Cipla Limited is a small archive contributor
Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.
Similar recall count
Nearest multi-notice firms by distinct-event totals (3 here).
Similar drugs volume
Nearest multi-notice firms that share this firm's dominant product category.
Frequently Asked Questions
How many federal recall notices name Cipla Limited? ▼
Where does Cipla Limited sit among other recalling firms? ▼
Which agency issues most of Cipla Limited's notices? ▼
What product category dominates Cipla Limited's filing book? ▼
Is a higher notice count more dangerous? ▼
Firm-level totals aggregate distinct federal recall events naming Cipla Limited; individual notices remain authoritative on each linked recall page.
Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026